Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00347360 · ClinicalTrials.gov registry record · Phase 3
The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
- 654
- Enrollment target
NCT00347360 is a Phase 3 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 654 participants.
The verdict
NCT00347360, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 654 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, double-dummy, parallel group trial employing 15 cells of a 4x4 factorial design (no placebo)to compare the hypertensive effects in patients with Stage 1 and Stage 2 hypertension of carvedilol (20, 40 or 80 mg daily) alone, lisinopril (10, 20 or 40 mg daily) alone, and all combinations of the doses.
Interventions
- DRUG lisinopril
- DRUG carvedilol controlled release formulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 654 participants |
| Start Date | 2006-07 |
| Est. Completion | 2008-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00347360
The ClinicalTrials.gov registry entry for NCT00347360 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 654 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lisinopril is the first listed.
NCT00347360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00347360 about?
NCT00347360 is a clinical study titled "The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial". This is a randomized, double-blind, double-dummy, parallel group trial employing 15 cells of a 4x4 factorial design (no placebo)to compare the hypertensive effects in patients with Stage 1 and Stage 2 hypertension of carvedilol (20, 40 or 80 mg daily) alone, lisinopril (10, 20 or 40 mg daily) alone,...
What is the current status of trial NCT00347360?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 654 participants. The study started on 2006-07. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00347360?
The interventions under investigation include: lisinopril (DRUG), carvedilol controlled release formulation (DRUG).
Who is sponsoring clinical trial NCT00347360?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.